Insider Selling: MiMedx Group, Inc. (NASDAQ:MDXG) CAO Sells 54,596 Shares of Stock

MiMedx Group, Inc. (NASDAQ:MDXG) CAO William Frank Iv Hulse sold 54,596 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $7.89, for a total value of $430,762.44. Following the completion of the transaction, the chief accounting officer now directly owns 440,178 shares of the company’s stock, valued at approximately $3,473,004.42. The trade was a 11.03 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

William Frank Iv Hulse also recently made the following trade(s):

• On Monday, March 10th, William Frank Iv Hulse sold 81,446 shares of MiMedx Group stock. The shares were sold at an average price of $7.80, for a total value of $635,278.80.

MiMedx Group Stock Up 0.4 %

NASDAQ MDXG opened at $7.92 on Friday. The stock has a fifty day moving average of $8.45 and a 200-day moving average of $7.82. The stock has a market capitalization of $1.17 billion, a P/E ratio of 14.40 and a beta of 1.97. MiMedx Group, Inc. has a 52 week low of $5.47 and a 52 week high of $10.14. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10.

MiMedx Group (NASDAQ:MDXG) last released its earnings results on Wednesday, February 26th. The company reported $0.07 EPS for the quarter, meeting the consensus estimate of $0.07. The company had revenue of $92.91 million during the quarter, compared to analysts’ expectations of $89.42 million. MiMedx Group had a return on equity of 26.21% and a net margin of 23.86%. On average, equities research analysts forecast that MiMedx Group, Inc. will post 0.3 EPS for the current year.

Institutional Investors Weigh In On MiMedx Group

Hedge funds and other institutional investors have recently made changes to their positions in the company. Principal Financial Group Inc. boosted its position in shares of MiMedx Group by 6.3% in the 3rd quarter. Principal Financial Group Inc. now owns 55,495 shares of the company’s stock worth $328,000 after purchasing an additional 3,292 shares during the last quarter. Entropy Technologies LP bought a new position in shares of MiMedx Group in the 3rd quarter worth $64,000. Aigen Investment Management LP bought a new position in shares of MiMedx Group in the 3rd quarter worth $83,000. Victory Capital Management Inc. boosted its position in shares of MiMedx Group by 2.8% in the 3rd quarter. Victory Capital Management Inc. now owns 142,350 shares of the company’s stock worth $841,000 after purchasing an additional 3,901 shares during the last quarter. Finally, Royce & Associates LP boosted its position in shares of MiMedx Group by 5.3% in the 3rd quarter. Royce & Associates LP now owns 972,853 shares of the company’s stock worth $5,750,000 after purchasing an additional 48,539 shares during the last quarter. 79.15% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $13.00 price target on shares of MiMedx Group in a report on Thursday, February 27th.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.